From: Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study
Treatment sequence
Subjects, n
Treatment period
1
2
3
A
5
Placebo
2.5Â mg
10Â mg
B
5Â mg
20Â mg
C
40Â mg
D
60Â mg
E
F
G
Total
35a